4.7 Article

Plasma Rich in Growth Factors as an Adjuvant Agent in Non-Penetrating Deep Sclerectomy

Related references

Note: Only part of the references are listed.
Review Ophthalmology

The developments in amniotic membrane transplantation in glaucoma and vitreoretinal procedures

Rohit Sharma et al.

Summary: The main reasons for transplanting amniotic membrane (AM) in ophthalmology are to promote cellular growth, provide tectonic support, protect the wound, and facilitate wound healing. It has been widely used in corneal disorders and has shown potential in conjunctival disorders, glaucoma, and vitreoretinal procedures. Studies have shown that AM transplant with trabeculectomy can effectively improve intraocular pressure and enhance the success rate of trabeculectomies when used with mitomycin C. AM has also been used as a tectonic support in shunt procedures and has shown successful results in vitreoretinal procedures. However, further studies are needed to refine surgical techniques and better understand its therapeutic effects.

INTERNATIONAL OPHTHALMOLOGY (2023)

Review Biotechnology & Applied Microbiology

Progress in the use of plasma rich in growth factors in ophthalmology: from ocular surface to ocular fundus

E. Anitua et al.

Summary: The use of blood derivatives, specifically Plasma rich in growth factors (PRGF), has become increasingly popular in the fields of oral surgery, dermatology, orthopedics, and more recently in ophthalmology over the past decades. PRGF, a type of platelet-rich plasma, is being explored for its therapeutic potential in treating ocular injuries. With a wide range of formulations available, PRGF technology shows promising results in the treatment of various acute and chronic ocular pathologies.

EXPERT OPINION ON BIOLOGICAL THERAPY (2022)

Article Medicine, General & Internal

Plasma Rich in Growth Factors in Macular Hole Surgery

Ronald M. Sanchez-Avila et al.

Summary: This study evaluated the use of PRGF as an adjuvant therapy to PPV in MH surgery. The results showed that PRGF can improve anatomical closure and visual acuity in MH surgery.

CLINICS AND PRACTICE (2022)

Article Ophthalmology

Long-term results of autologous plasma as adjuvant to pars plana vitrectomy in the treatment of high myopic full-thickness macular holes

Marta S. Figueroa et al.

Summary: The study findings suggest that using PRGF as an adjuvant to pars plana vitrectomy in high myopic FTMH treatment is effective, with a high rate of FTMH resolution postoperatively. Specific preoperative factors were identified to predict the improvement of postoperative visual acuity.

EUROPEAN JOURNAL OF OPHTHALMOLOGY (2021)

Article Medicine, General & Internal

Plasma rich in growth factors membrane as coadjuvant treatment in the surgery of ocular surface disorders

Ronald M. Sanchez-Avila et al.

MEDICINE (2018)

Article Ophthalmology

Plasma Rich in Growth Factors for the Treatment of Dry Eye after LASIK Surgery

Ronald Mauricio Sanchez-Avila et al.

OPHTHALMIC RESEARCH (2018)

Article Medicine, General & Internal

Plasma rich in growth factors eye drops to treat secondary ocular surface disorders in patients with glaucoma

Ronald M. Sanchez-Avila et al.

INTERNATIONAL MEDICAL CASE REPORTS JOURNAL (2018)

Article Ophthalmology

Baerveldt tube implantation following failed deep sclerectomy versus repeat deep sclerectomy

C. Bergin et al.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2016)

Review Biotechnology & Applied Microbiology

Anterior Segment Optical Coherence Tomography Imaging of Conjunctival Filtering Blebs after Glaucoma Surgery

Rodolfo Mastropasqua et al.

BIOMED RESEARCH INTERNATIONAL (2014)

Review Medicine, General & Internal

Non-penetrating filtration surgery versus trabeculectomy for open-angle glaucoma

Mohamed A. Eldaly et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)

Article Ophthalmology

Supraciliary Hema Implant in Combined Deep Sclerectomy and Phacoemulsification: One Year Results

Rosa Bonilla et al.

OPEN OPHTHALMOLOGY JOURNAL (2012)

Review Ophthalmology

Future Target Molecules in Antiglaucoma Therapy: TGF-beta May Have a Role to Play

Renu Agarwal et al.

OPHTHALMIC RESEARCH (2010)

Article Ophthalmology

Ten Years Follow-up After Deep Sclerectomy With Collagen Implant

Alexandre Bissig et al.

JOURNAL OF GLAUCOMA (2008)

Review Ophthalmology

Nonpenetrating Glaucoma Surgery

Efstratios Mendrinos et al.

SURVEY OF OPHTHALMOLOGY (2008)

Article Ophthalmology

Complications of deep nonpenetrating sclerectomy

S. Roy et al.

JOURNAL FRANCAIS D OPHTALMOLOGIE (2006)

Article Ophthalmology

Long-term results of deep sclerectomy with collagen implant

T Shaarawy et al.

JOURNAL OF CATARACT AND REFRACTIVE SURGERY (2004)